What Types of Cancer Can AI Help Detect Earlier in Scans?

Where Research Attention Has Concentrated

AI-assisted image analysis for cancer detection has been studied most extensively in cancer types that already have well-established, image-based screening programs, since these programs have generated the kind of large, standardized imaging datasets needed to train and validate machine learning models. Breast cancer screening through mammography is a prominent example: it has a long history of routine, structured imaging and substantial historical data, making it a natural area for AI research aimed at helping radiologists identify suspicious findings that may warrant further evaluation.

Lung cancer screening using low-dose CT scans is another significant area of focus, particularly given the importance of identifying nodules that could represent early-stage disease. Researchers have also explored AI-assisted analysis of skin lesion images as a tool that could help flag features associated with skin cancer for closer evaluation by a dermatologist.

What “Help Detect” Actually Means in Practice

Across all of these applications, it’s important to understand precisely what role AI plays. These tools are generally studied and used as an aid to flag areas of a scan or image that show patterns associated with potential concern, directing a specialist’s attention toward findings that may deserve closer review. This is meaningfully different from AI independently diagnosing cancer. A flagged area still requires follow-up: a radiologist’s own interpretation, and in many cases, additional diagnostic procedures such as a biopsy and pathology examination, which remain the standard way an actual cancer diagnosis gets confirmed.

This distinction matters because a flagged finding is not itself a diagnosis, and framing it as one would overstate both what these tools do and what they’ve been validated to do.

Why Earlier Flagging Can Matter

The broader motivation behind this area of research is that, for certain cancers, detecting suspicious findings earlier — when a cancer may be smaller or less advanced — can be clinically significant, which is part of why routine screening programs exist for cancers like breast and lung cancer in eligible populations to begin with. AI tools that can help a radiologist notice a subtle finding they might have otherwise reviewed more quickly, or that can help prioritize which scans deserve most urgent review in a busy screening program, are being explored as a way to support the existing goals of these established screening efforts rather than to change what screening programs are fundamentally trying to accomplish.

Bottom Line

AI-assisted imaging analysis has been studied most extensively for cancers with established screening programs, including breast, lung, and skin cancer, where it’s used to help flag suspicious findings for a specialist’s closer review — not to independently diagnose cancer, which still requires further clinical evaluation and, typically, a biopsy.

Go deeper

• How is AI used to diagnose disease in areas with limited access to doctors?
• Are AI Tenant Screening Tools Legal Under Fair Housing Law?
• What Are Legal Aid Organizations Doing With AI Chatbots?